Owens & Minor (OMI) Misses Q4 EPS by 3c, Reaffirms FY16 Guidance

Owens & Minor (NYSE: OMI) reported Q4 EPS of $0.46, $0.03 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $2.49 billion versus the consensus estimate of $2.51 billion.

2016 Outlook

The company reiterated its financial guidance for 2016, consistent with the guidance originally provided at its December 2015 Investor Day.

For 2016, the company is targeting adjusted earnings per diluted share in a range of $2.00 to $2.05.

For earnings history and earnings-related data on Owens & Minor (OMI) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
• Utah Medical Products (UTMD) Reports Q1 EPS of $1.10